Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -38.37% | -77.25% | -0.90% | -16.00% | 33.63% |
| Total Depreciation and Amortization | 2.34% | -1.60% | 1.46% | 0.18% | 0.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.29% | 173.14% | 2.21% | 38.82% | -50.29% |
| Change in Net Operating Assets | 43.27% | 437.84% | -164.44% | -182.86% | -100.93% |
| Cash from Operations | 32.56% | 63.06% | -26.61% | -38.06% | -31.85% |
| Capital Expenditure | 74.31% | -123.47% | -- | -- | -90.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 74.31% | -123.47% | -- | -- | -158.29% |
| Total Debt Issued | -43.18% | -84.40% | 38.70% | 6.67% | -4.57% |
| Total Debt Repaid | -49.12% | 43.86% | 42.17% | -27.61% | -6.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 99.50% |
| Cash from Financing | -44.38% | -85.33% | 23.48% | 11.83% | -0.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.23% | -167.00% | -22.62% | -66.50% | -653.41% |